Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Shares Outstanding (Diluted Average) (2021 - 2024)

LifeStance Health (LFST) has disclosed Shares Outstanding (Diluted Average) for 4 consecutive years, with $379.1 million as the latest value for Q4 2024.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 3.18% to $379.1 million in Q4 2024 year-over-year; TTM through Dec 2024 was $379.1 million, a 3.18% increase, with the full-year FY2024 number at $379.1 million, up 3.18% from a year prior.
  • Shares Outstanding (Diluted Average) was $379.1 million for Q4 2024 at LifeStance Health, roughly flat from $378.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $379.1 million in Q4 2024 to a low of $327523.0 in Q4 2021.
  • A 4-year average of $256.3 million and a median of $362.0 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): surged 108374.21% in 2022, then grew 1.67% in 2024.
  • LifeStance Health's Shares Outstanding (Diluted Average) stood at $327523.0 in 2021, then soared by 108374.21% to $355.3 million in 2022, then increased by 3.43% to $367.5 million in 2023, then rose by 3.18% to $379.1 million in 2024.
  • Per Business Quant, the three most recent readings for LFST's Shares Outstanding (Diluted Average) are $379.1 million (Q4 2024), $378.7 million (Q3 2024), and $377.9 million (Q2 2024).